MODTX (MODTX) News
Follow MODTX (MODTX) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Modus Therapeutics Pauses Phase IIa Enrollment After SUSAR
The company voluntarily paused enrollment in Part 2 of its Phase IIa sevuparin CKD anemia study after a reported SUSAR, shifting the expected proof-of-concept readout to Q1 2027. Cash is expected to fund operations into
EQUITY | Oct 14, 2026, 06:30 PM UTC
L
Modus Gets SEK 0.13 Mln Through Exercise Of Warrants
Modus Therapeutics Holding AB OMXSTO:MODTX
NEWS | Sep 29, 2026, 12:18 PM UTC
L
Modus Therapeutics resolves directed share issue of 20 million shares
Modus Therapeutics Holding AB resolved an on-directed share issue of 20 million shares.
EQUITY | Sep 04, 2026, 05:57 AM UTC
L
Modus Therapeutics resolves directed share issue at SEK 0.38
Modus Therapeutics’ board resolved a directed new issue of 20,000,000 shares at a subscription price of SEK 0.38, pursuant to AGM authorisation from 28 May 2026.
EQUITY | Sep 03, 2026, 08:00 PM UTC